US2003209291A1PendingUtilityA1

Products and methods

Priority: Jun 11, 1999Filed: Jun 2, 2003Published: Nov 13, 2003
Est. expiryJun 11, 2019(expired)· nominal 20-yr term from priority
C23C 22/68G21G 4/06A61N 5/1001A61N 2005/1019G21G 4/08
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for the immobilisation of a radioactive anion on the surface of a metal substrate, said method comprising treating the substrate with an oxidising agent in the presence of a solution of a radioactive anion which forms an insoluble salt with ions of said metal. Preferably, a binding agent will also be present. Preferably, the metal is silver, the radioactive anion is 125 I − and the binding agent comprises bromide ions.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for the immobilisation of a radioisotope on the metal surface of a substrate, said method comprising treating the substrate with an oxidising agent in the presence of a source of a radioactive anion wherein the oxidising agent is capable of oxidising the metal to the corresponding metal ion, and the radioactive anion is capable of forming an insoluble salt with said metal cation.  
     
     
         2 . The method of  claim 1 , wherein the metal is selected from the group consisting of silver, gold, copper and lead.  
     
     
         3 . The method of  claim 2 , wherein the metal is silver.  
     
     
         4 . The method of  claim 1 , wherein the radioactive anion comprises  125 I,  35 S or  32 P.  
     
     
         5 . The method of  claim 1 , wherein the radioactive anion is selected from the group consisting of  125 I − ,  131 I − ,  123 I − ,  35 S 2− ,  35 SO 4   2− ,  35 SO 3   2− ,  125 IO 3   − ,  131 IO 3   − ,  123 IO 3   − ,  51 CrO 4   2− ,  32 PO 4   3− , H 32 PO 4   2− , H 2   32 PO 4   −  and H 3   32 P 2 O 7   − .  
     
     
         6 . The method of  claim 5 , wherein the radioactive anion is  125 I − .  
     
     
         7 . The method of  claim 1  which further comprises adding a binding agent.  
     
     
         8 . The method of  claim 7 , wherein the metal is silver and the radioactive anion is  125 I − .  
     
     
         9 . The method of  claim 8 , wherein the binding agent comprises bromide or chloride ions.  
     
     
         10 . The method of  claim 1 , wherein the oxidising agent is selected from the group consisting of sodium chlorite (NaClO 2 ), sodium chlorate (NaClO 3 ), sodium chromate (Na 2 CrO 4 ), hydrogen peroxide (H 2 O 2 ), potassium dichromate (K 2 Cr 2 O 7 ), potassium permanganate (KMnO 4 ), and potassium ferricyanide (K 3 Fe(CN) 6 ).  
     
     
         11 . The method of  claim 10 , wherein the oxidising agent is potassium ferricyanide.  
     
     
         12 . The method of  claim 11  which further comprises adding potassium ferrocyanide, to a molar ratio of Fe(CN) 6   3− :[Fe(CN) 6   4−  of about 10:1 at the start of the oxidising reaction.  
     
     
         13 . The method of  claim 1 , wherein the source of the radioactive anion comprises a solution or dispersion.  
     
     
         14 . The method of  claim 1 , wherein the immobilisation takes place in a solution comprising an elevated concentration of a salt additive.  
     
     
         15 . The method of  claim 14 , wherein the salt additive is NaCl, KCl, CsCl, LiCl, CaCl 2 , NaNO 3  or MgCl 2 .  
     
     
         16 . The method of  claim 14 , wherein the concentration of the salt additive is in the range of about 0.01 molar to the saturation level of the added salt.  
     
     
         17 . A radioactive metal substrate prepared by the method as of  claim 7 .  
     
     
         18 . A radioactive source for use in brachytherapy comprising a radioactive metal substrate prepared by the method of  claim 1 .  
     
     
         19 . A radioactive source for use in brachytherapy comprising the radioactive metal substrate of  claim 17 .  
     
     
         20 . The method of  claim 1  wherein the source of the radioactive anion comprises two or more radioisotopes.

Join the waitlist — get patent alerts

Track US2003209291A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.